Skip to main content
SpringerLink
Log in

(Primary) hemifacial spasm: epidemiological data

  • Chapter
Hemifacial Spasm

  • 120 Accesses

Summary

Epidemiological and clinical analyses of hemifacial spasm (HFS) are presented and pertinent literature is reviewed. A group of 61 patients with HFS treated with botulinum toxin (BT) was studied, and a structured questionnaire took into account: age at onset (range: 18–77, mean: 51.1 years) and age at time of initiation of treatment (range: 22–82, mean: 58.1 years), sex distribution (showing a female predominance: 70%), side distribution (showing a predominant involvement of the left side of the face: 67%), initiation and evolution of HFS, personal and family history, symptoms associated with HFS, and response to treatment given before BT. Data on age, sex, and side distributions on these 61 patients were compared to those obtained in a group of 50 patients with HFS who underwent operation to perform vascular decompression. All of the parameters that were analyzed in patients with HFS were compared to those obtained in patients with blepharospasm (BSP). Thus, 57 patients with BSP treated with BT were age-matched with a similar number of the patients with HFS (belonging to the group of 61 patients).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adenis JP, Smolik I, Maes S (1990) Traitement des spasmes faciaux par la toxine botulinique A. J Fr Ophtalmol 13: 259–264

    PubMed  CAS  Google Scholar 

  2. Auger RG (1979) Hemifacial spasm: Clinical and electrophysiologic observations. Neurology 29: 1261–1272

    PubMed  CAS  Google Scholar 

  3. Auger RG, Whisnant JP (1990) Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984. Arch Neurol 47: 1233–1234

    PubMed  CAS  Google Scholar 

  4. Babinski J (1905) Hémispasme facial périphérique. Rev Neurol (Paris) 13: 151–158

    Google Scholar 

  5. Ballantyne ES, Page RD, Meaney JFM, Nixon TE, Miles JB (1994) Coexistent trigeminal neuralgia, hemifacial spasm, and hypertension: Preoperative imaging of neurovascular compression. J Neurosurg 80: 559–563

    Article  PubMed  CAS  Google Scholar 

  6. Benillouche P (1993) Traitement du blépharospasme et de l’hémispasme facial par la toxine botulique A. Etude rétrospective de 173 patients. Thèse de Doctorat en Médecine, Université Claude Bernard Lyon I

    Google Scholar 

  7. Biglan AW, May M, Bowers RA (1988) Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum). Arch Otolaryngol Head Neck Surg 114: 1407–1412

    PubMed  CAS  Google Scholar 

  8. Brissaud E (1895) Tics et spasmes cloniques de la face: Vingt-quatrième leçon. In: Meige H (ed) Leçons sur les maladies nerveuses, Paris, Salpétrière 1893–1894. Masson, Paris, pp 502–520

    Google Scholar 

  9. Coad JE, Wirtschafter JD, Haines SJ, Heros RC, Perrone T (1991) Familial hemifacial spasm associated with arterial compression of the facial nerve. J Neurosurg 74: 290–296

    Article  PubMed  CAS  Google Scholar 

  10. Cushing H (1920) The major trigeminal neuralgias and their surgical treatment based on experience with 332 gasserian operations. Am J Med Sci 160: 157–184

    Article  Google Scholar 

  11. Digre K, Corbett JJ (1988) Hemifacial spasm: Differential diagnosis, mechanism, and treatment. In: Jankovic J, Tolosa E (eds) Advances in neurology, vol. 49: Facial dyskinesias. Raven Press, New York, pp 151–176

    Google Scholar 

  12. Dutton JJ, Buckley EG (1988) Long-term results and complications of Botulinum A toxin in the treatment of blepharospasm. Ophthalmology 95: 1529–1534

    PubMed  CAS  Google Scholar 

  13. Ehni G, Woltman HW (1945) Hemifacial spasm. Review of one hundred and six cases. Arch Neurol Psychiatry 53: 205–211

    Google Scholar 

  14. Elston JS (1986) Botulinum toxin treatment of hemifacial spasm. J Neurol Neurosurg Psychiatry 49: 827–829

    Article  PubMed  CAS  Google Scholar 

  15. Elston JS (1988) Botulinum toxin therapy for involuntary facial movement. Eyes 2: 12–15

    Article  Google Scholar 

  16. Elston JS (1992) The management of blepharospasm and hemifacial spasm. J Neurol 239: 5–8

    Article  PubMed  CAS  Google Scholar 

  17. Esteban A, Molina-Negro P (1986) Primary hemifacial spasm: A neurophysiological study. J Neurol Neurosurg Psychiatry 49: 58–63

    Article  PubMed  CAS  Google Scholar 

  18. Flanders M, Chin D, Boghen D (1993) Botulinum toxin: Preferred treatment for hemifacial spasm. Eur Neurol 33: 316–319

    Article  PubMed  CAS  Google Scholar 

  19. Gardner WJ, Sava GA (1962) Hemifacial spasm-a reversible pathophysiologic state. J Neurosurg 19: 240–247

    Article  Google Scholar 

  20. Geller BD, Hallett M, Ravits J (1989) Botulinum toxin therapy in hemifacial spasm: Clinical and electrophysiologic studies. Muscle and Nerve 12: 716–722

    Article  PubMed  CAS  Google Scholar 

  21. Gonnering RS (1986) Treatment of hemifacial spasm with botulinum A toxin. Results and rationale. Ophthal Plast Reconstr Surg 2: 143–146

    Article  PubMed  CAS  Google Scholar 

  22. Gowers WR (1888) A manual of diseases of the nervous system. P. Blakiston, Philadelphia

    Google Scholar 

  23. Huang CI, Chen IH, Lee LS (1992) Microvascular decompression for hemifacial spasm: Analyses of operative findings and results in 310 patients. Neurosurgery 30: 53–57

    Article  PubMed  CAS  Google Scholar 

  24. Iwakuma T, Matsumoto A, Nakamura N (1982) Comparison of three different operative procedures in 110 patients. J Neurosurg 57: 753–756

    Article  PubMed  CAS  Google Scholar 

  25. Jankovic J, Schwartz K, Donovan DT (1990) Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 53: 633–639

    Article  PubMed  CAS  Google Scholar 

  26. Jannetta PJ, Abbasy M, Maroon JC, Ramos FM, Albin MS (1977) Etiology and definitive microsurgical treatment of hemifacial spasm. J Neurosurg 47: 321–328

    Article  PubMed  CAS  Google Scholar 

  27. Jannetta PJ (1981) Hemifacial spasm. In: Samii M, Jannetta PJ (eds) The cranial nerves. Springer, Heidelberg, pp 484–493

    Google Scholar 

  28. Jedynak CP, Palfi S, Vidailhet M, Kullmann B (1993) Traitement du spasme hémifacial par la toxine botulique. Rev Neurol (Paris) 149: 202–206

    CAS  Google Scholar 

  29. Katusic SK, Beard CM, Bergstralh EJ, Kurland LT (1990) Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984. Ann Neurol 27: 89–95

    Article  PubMed  CAS  Google Scholar 

  30. Katusic SK, Beard CM, Wiederholt WC, Bergstralh EJ, Kurland LT (1986) Incidence, clinical features and prognosis in Bell’s palsy, Rochester, Minnesota, 1968–1982. Ann Neurol 20: 622–627

    Article  PubMed  CAS  Google Scholar 

  31. Kraft SP, Lang AE (1988) Cranial dystonia, blepharospasm and hemifacial spasm: Clinical features and treatment, including the use of botulinum toxin. Can Med Assoc J 139: 837–844

    CAS  Google Scholar 

  32. Mauriello JA, Aljian J (1991) Natural history of treatment of facial dyskinesias with botulinum toxin: A study of 50 consecutive patients over seven years. Br J Ophthalmol 75: 737–739

    Article  PubMed  CAS  Google Scholar 

  33. Newton TH, Mani RL (1974) The vertebral artery. In: Newton TH, Potts DG (eds) Radiology of the skull and brain. Angiography. CV Mosby, St Louis, pp 1659–1709

    Google Scholar 

  34. Nielsen VK (1984) Pathophysiology of hemifacial spasm: I. Ephaptic transmission and ectopic excitation. Neurology 34: 418–426

    PubMed  CAS  Google Scholar 

  35. Rosso ALZ, Mattos JP, Fogel LM, Novis SAP (1994) Bilateral hemifacial spasm. Mov Disord 9: 236

    Article  PubMed  CAS  Google Scholar 

  36. Ruban JM, Pellissier de Feligonde O, Benillouche P (1993) Analyse de l’efficacité de la toxine botulique A dans le traitement du blépharospasme et de l’hémispasme facial. A propos de 160 cas. Ophtalmologie 7: 481–482

    Google Scholar 

  37. Saraux H (1988) Traitement des blépharospasmes et des hémispasmes faciaux par injection de toxine botulique. J Fr Ophtalmol 11: 237–240

    PubMed  CAS  Google Scholar 

  38. Savino PJ, Sergott RC, Bosley TM, Schatz N (1985) Hemifacial spasm treated with botulinum A toxin injection. Arch Ophthalmol 103: 1305–1306

    PubMed  CAS  Google Scholar 

  39. Schultze F (1875) Linksseitiger Facialiskrampf in folge eines Aneurysma der Arteria vertebralis sinistra. Arch Pathol Anat 65: 385–391

    Article  Google Scholar 

  40. Shaywitz BA (1974) Hemifacial spasm in childhood treated with carbamazepine. Arch Neurol 31: 63

    PubMed  CAS  Google Scholar 

  41. Sindou M, Amrani F, Mertens P (1990) Décompression vasculaire microchirurgicale pour névralgie du trijumeau. Neurochirurgie 36: 16–26

    PubMed  CAS  Google Scholar 

  42. Soulayrol S, Caperan A, Penot-Ragon C, Beaulieu JP, Gastaut JL (1993) Traitements par injections locales de toxine botulique en neurologie. Presse Méd 22: 957–963

    PubMed  CAS  Google Scholar 

  43. Taylor JDN, Kraft SP, Kazdan MS, Flanders M, Cadera W, Orton RB (1991) Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: A Canadian multicentre study. Can J Ophthalmol 26: 133–138

    PubMed  CAS  Google Scholar 

  44. Tolosa E, Marti MJ, Kulisevsky J (1988) Botulinum toxin injection therapy for hemifacial spasm. In: Jankovic J, Tolosa E (eds) Advances in neurology, vol. 49: Facial dyskinesias. Raven Press, New York, pp 479–491

    Google Scholar 

  45. Wartenberg R (1952) Hemifacial spasm, a clinical and pathophysiological study. Oxford University Press, New York

    Google Scholar 

  46. Yu YL, Fong KY, Chang CM (1992) Treatment of idiopathic hemifacial spasm with botulinum toxin. Acta Neurol Scand 85: 55–57

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Botulinum Toxin Outpatient Clinic, Hopital Neurologique Pierre Wertheimer, Lyon, France

    A. Vighetto M.D. & C. Vial

Authors
  1. A. Vighetto M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Vial
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital Neurologique, Lyon, France

    Marc Sindou

  2. Hôpital Henri Mondor, Creteil, France

    Yves Keravel

  3. Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, USA

    Aage R. Møller

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag/Wien

About this chapter

Cite this chapter

Vighetto, A., Vial, C. (1997). (Primary) hemifacial spasm: epidemiological data. In: Sindou, M., Keravel, Y., Møller, A.R. (eds) Hemifacial Spasm. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6829-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6829-5_5

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7416-6

  • Online ISBN: 978-3-7091-6829-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation